Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Research

| More

InterGlobe Aviation - No qualms on survival is the investment thesis - ICICI Securities

Posted On: 2020-07-29 22:14:58


Based on the existing free cash, cost cutting measures and additional Rs50bn liquidity available, InterGlobe Aviation (IndiGo) remains well positioned to weather the Covid-19 impact. This is the singular, yet, very germane investment thesis considering the robust long-term potential of Indian air traffic and the weak market position of competitors. We value IndiGo at 20x core FY22 earnings (ex- investment income) of Rs18bn and add expected free cash balance of Rs130bn in FY22. Our target price stands at Rs1,270 (unchanged). Maintain BUY.

- Free cash dips Rs14bn QoQ (Rs75.2bn in Q1FY21 from Rs89.3bn in Q1FY20). IndiGo had a cash burn (total fixed costs less the contribution from flights in operation) of Rs400mn per day in April, which has subsequently declined to Rs300mn in June. Assuming there was an average Rs350mn/day of cash burn in the quarter, the total Q1 cash burn would be ~Rs31.5bn. We estimate cash receipt of ~Rs6.5bn from the sale and leaseback of 12 neo aircraft received in Q1FY21. Hence, net of SLB profits, cash loss would be Rs25bn. This translates to total savings of Rs11bn through vendor/lessor negotiations, which would lead to Rs14bn of ultimate cash decline QoQ.

- How long will free cash last? Based on Q1FY21 run rate and considering IndiGo is following a strategy of continued induction of neos, the present free cash of Indigo will last for (1) four quarters even without any vendor negotiations and (2) seven quarters including the impact of negotiations seen in Q1FY21. There is additional available liquidity of Rs50bn through sale and leaseback of owned aircraft and other cost cuts. Hence, we believe, there are no qualms on survival for IndiGo.

- CASK should improve in FY22 (estimated Rs3.50) over FY20 (actual Rs3.74). This is primarily driven by lower maintenance and fuel expense of neos and cost savings. We factor CASK ex-fuel of Rs2.43 in FY22 compared to Rs2.45 in FY20. Our CASK includes all operating cost along with fuel and depreciation. Fuel CASK is expected to decline from Rs1.3 in FY20 to Rs1.07 in FY22E (assuming Rs50,000/kl of ATF vs Rs35,000 in June2020).

- Market share increase has slowly started playing out, can gain further momentum. Jun'20 market share for IndiGo stood at 53% vs 48% in Jan'20.

- We factor RASK of Rs3.65 for IndiGo in FY22E compared to Rs3.72 in FY20. We factor ASK growth of 10% between FY20 and FY22 with passenger count dropping from 74mn in FY22 to 69mn in FY22 (26mn in FY21).

- CASK should improve in FY22 (estimated Rs3.45) over FY20 (actual Rs3.74). This is primarily driven by lower maintenance and fuel expense of neos and cost savings from employee and other expense. We factor CASK ex-fuel of Rs2.37 in FY22 compared to Rs2.45 in FY20. Our CASK includes all operating cost along with fuel and depreciation. Fuel CASK is expected to decline from Rs1.3 in FY20 to Rs1.07 in FY22E (assuming Rs50,000/kl of ATF vs Rs35,000 in June2020).

Valuations and assumptions

We value IndiGo at 20x core FY22 earnings (ex-investment income) of Rs18bn and add expected free cash balance of Rs130bn in FY22. Our unchanged target price stands at Rs1,270. Maintain BUY.

Shares of InterGlobe Aviation Ltd was last trading in BSE at Rs.909.8 as compared to the previous close of Rs. 913.9. The total number of shares traded during the day was 109182 in over 6526 trades.

The stock hit an intraday high of Rs. 922.75 and intraday low of 899. The net turnover during the day was Rs. 99591545.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

HeidelbergCement India - Play on better priced Central India; initiate with BUY - ICICI Securities

Healthcare - Diagnostics: Multiple tailwinds likely to emerge - ICICI Securities

Mazagon Dock Shipbuilders Ltd - IPO Review - ICICI Securities

Persistent Systems - 28th September 2020 - Angel Broking

Canara Bank - 28th September 2020 - Angel Broking

Subscribe to UTI Asset Management Company Limited - IPO Note - Angel Broking

Multiplex Sector - Mr. Jyoti Roy - DVP - Equity Strategist, Angel Broking Ltd

Sale of Sequent stake to Strides Pharma - Angel Broking

Subscribe to Mazagon Dock Shipbuilders Ltd - IPO Note - Angel Broking

JSW Energy - First big renewable step - ICICI Securities

V-MART Retail - Best play in value fashion segment; initiating with BUY - ICICI Securities

Gas sector - New winners and losers likely on policy changes in gas sector - ICICI Securities

Mazagon Dock Shipbuilders Limited - IPO Note - Geojit

UTI Asset Management Company Limited - IPO Note - Geojit

Preview on RBI Monetary Policy - Oct 2020 - Shanti Ekambaram

Rollover Report for September 2020 - October 2020: Angel Broking

Covid Recovery Pulse - Sep 25, 2020 - ICICI Securities

Quick Comment - Suven Pharmaceuticals - ICICI Securities

Derivatives Strategy - Sep 25, 2020 - Positional Option - ICICI Securities

Gladiator Stocks - Ramco Cement - ICICI Securities

IPO Review - UTI Asset Management Company - ICICI Securities

Stock of the Day - Zensar Technologies - Sep 25, 2020 - Angel Broking

Accenture Q4FY2020 Result - Angel Broking

Granules India receives ANDA approval - Angel Broking

Zydus Cadila receives US FDA approval - Angel Broking

Cipla - ANDA approval - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Mindspace REIT - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

UTI AMC - IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

Balkrishna Industries - Growth momentum continues - ICICI Securities

Rollover Analysis (September 25): Nifty starts October series with low OI amid high volatility

Derivatives View (September 25): Sell Bank Nifty in range of 20650-20750 - ICICI Securities

Rollover Analysis - Sept 20: Selling climax on expiry as markets crumble - YES Securities

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot

Bharat Forge - Expectation hurdle remains steep - ICICI Securities

Auto

Mutual Fund Review - September, 2020 - ICICI Securities

UTI AMC announces IPO date - Angel Broking

Asian Paints - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Britannia Industries - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Hexaware Technologies (Not Rated): Hexaware accepts 475/share as final delisting price - ICICI Securities

CAMS IPO - Day 2 Subscription - Angel Boking

Chemcon Speciality Chemicals - IPO subscribed 12.62 times on second day - Angel Broking







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019